Stacey E. Brenner, Ph.D. - Publications

2005 Stanford University, Palo Alto, CA 
Organic, Organometallic, Bioorganic, and Medicinal Chemistry

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2011 Wender PA, Baryza JL, Brenner SE, DeChristopher BA, Loy BA, Schrier AJ, Verma VA. Design, synthesis, and evaluation of potent bryostatin analogs that modulate PKC translocation selectivity. Proceedings of the National Academy of Sciences of the United States of America. 108: 6721-6. PMID 21415363 DOI: 10.1073/pnas.1015270108  0.84
2009 McGarraugh PG, Brenner SE. Novel bifunctional sulfonamides catalyze an enantioselective conjugate addition. Tetrahedron. 65: 449-455. PMID 20066026 DOI: 10.1016/j.tet.2008.11.027  0.84
2009 McGarraugh PG, Brenner SE. A new organocatalyzed Michael-Michael cascade reaction generates highly substituted fused carbocycles. Organic Letters. 11: 5654-7. PMID 19921792 DOI: 10.1021/ol9024293  0.84
2006 Mitchell CE, Brenner SE, García-Fortanet J, Ley SV. An efficient, asymmetric organocatalyst-mediated conjugate addition of nitroalkanes to unsaturated cyclic and acyclic ketones. Organic & Biomolecular Chemistry. 4: 2039-49. PMID 16688349 DOI: 10.1039/b601877g  0.84
2005 Mitchell CE, Brenner SE, Ley SV. A versatile organocatalyst for the asymmetric conjugate addition of nitroalkanes to enones. Chemical Communications (Cambridge, England). 5346-8. PMID 16244750 DOI: 10.1039/b511441a  0.84
2004 Wender PA, Baryza JL, Brenner SE, Clarke MO, Craske ML, Horan JC, Meyer T. Function oriented synthesis: the design, synthesis, PKC binding and translocation activity of a new bryostatin analog. Current Drug Discovery Technologies. 1: 1-11. PMID 16472215  0.84
2004 Stone JC, Stang SL, Zheng Y, Dower NA, Brenner SE, Baryza JL, Wender PA. Synthetic bryostatin analogues activate the RasGRP1 signaling pathway. Journal of Medicinal Chemistry. 47: 6638-44. PMID 15588099 DOI: 10.1021/jm0495069  0.84
2004 Baryza JL, Brenner SE, Craske ML, Meyer T, Wender PA. Simplified analogs of bryostatin with anticancer activity display greater potency for translocation of PKCdelta-GFP. Chemistry & Biology. 11: 1261-7. PMID 15380186 DOI: 10.1016/j.chembiol.2004.06.014  0.84
2003 Wender PA, Baryza JL, Brenner SE, Clarke MO, Gamber GG, Horan JC, Jessop TC, Kan C, Pattabiraman K, Williams TJ. Inspirations from nature. New reactions, therapeutic leads, and drug delivery systems Pure and Applied Chemistry. 75: 143-155.  0.84
2002 Wender PA, Baryza JL, Bennett CE, Bi FC, Brenner SE, Clarke MO, Horan JC, Kan C, Lacôte E, Lippa B, Nell PG, Turner TM. The practical synthesis of a novel and highly potent analogue of bryostatin. Journal of the American Chemical Society. 124: 13648-9. PMID 12431074 DOI: 10.1021/ja027509+  0.84
Show low-probability matches.